Close Menu
    What's Hot

    Record Low Mortality Rates So Far in England and Wales in 2026

    July 9, 2026

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Lumos Insurance Hires Tom Kenny To Establish Reinsurance Operations

      June 9, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      STS Field Grant Limited Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      July 6, 2026

      Associated Board of the Royal Schools of Music Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

      July 2, 2026

      First Quarter US Pension Risk Transfer Sales Down Almost Half Compared to 2025

      July 2, 2026

      Constellation Institutional Markets Re-Enters Pension Risk Transfer Market

      July 2, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      UK Equity Release Market Waits on Fourth Quarter for Potentially Market-Altering Change

      June 24, 2026

      Q&A: James Westerlind, Partner, ArentFox Schiff

      June 24, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    UK Equity Release Market Waits on Fourth Quarter for Potentially Market-Altering Change

    Longevity and Mortality Risk Transfer June 24, 2026By Greg Winterton
    Share
    Twitter LinkedIn Email

    Like many developed economies, the UK’s later life lending market – mostly equity release mortgages – is sitting on a significant structural disconnect. While over-55s hold an estimated £3.7trn in property wealth, the equity release market remains small by comparison. Last year, total lending reached just £2.57bn according to industry group the Equity Release Council (ERC). While that represents an 11% increase from 2024, it accounts for a mere 0.07% of the total housing wealth held by older cohorts. 

    Change to support growth in this market, however, looks to be coming. The Financial Conduct Authority (FCA) is currently conducting a comprehensive market study into lifetime and retirement interest-only mortgages, with final findings expected in the fourth quarter of this year. Launched in March, the study aims to examine whether regulatory or structural shifts (or both) are required to bolster competition and provide new solutions to meet the changing needs of UK consumers, almost half of whom are not saving enough for retirement. 

    While ERC data showed a dip in lending during the first quarter of this year, citing uncertainty in UK and global economies slowing consumer decision-making, David Burrowes, Chair of the ERC, said that is not due to waning interest. 

    “What we’re seeing is not a lack of demand – enquiries are up – but a delay in cases coming through. Advisers are reporting strong levels of interest, but customers are taking more time and, in some cases, pausing decisions altogether,” he said. 

    “It could well be that we are set for an uplift as conditions stabilise and delayed cases begin to complete. Over the longer term, the underlying drivers of demand remain in place, and housing wealth continues to play an important role in supporting financial resilience later in life.” 

    The FCA appears to share this long-term view. Speaking at the Later Life Lending Summit, Emad Aladhal, Director of Retail Banking at the FCA, cited research from Fairer Finance indicating that by 2040, 51% of households aged 60 and over could benefit from accessing housing equity, unlocking around £23bn annually in today’s prices. 

    “That gives a sense of the scale of the opportunity,” Aladhal told attendees at the event. “We should not be talking about it as a market niche, but becoming part of a much bigger, everyday conversation about achieving financial resilience in later life.” 

    There are structural hurdles that must be cleared if the UK equity release market is to scale up from £2.57bn annually. While macroeconomic pressures like interest rates, which the Bank of England held at 3.75% in mid-June, sit outside the FCA’s purview, the availability of institutional funding seems to be a primary concern. 

    At the same summit, as reported by Shekina Tuahene of Mortgage Solutions, Ben Grainger, Partner at EY, said that the number of insurance companies funding equity release mortgages “is probably at an all-time low.” 

    The FCA’s terms of reference document that it published alongside the notification of the market study suggest it is acutely aware of this capital bottleneck. In his address, Aladhal noted that meeting consumer demand will require the provider market to expand via both incumbent growth and new entrants. 

    “We are concerned that existing providers and potential new entrants may face real barriers to growth and entry,” Aladhal said. “We’ve seen very little successful entry in recent years.” 

    While the FCA targets consumer outcomes and provider barriers from the top down, an additional tailwind from the Prudential Regulation Authority (PRA) is also on the horizon. 

    The PRA is currently working through CP2/26 – ‘Reforms to securitisation requirements’, a consultation paper that could increase the asset class’s appeal to institutional investors. The proposed introduction of more flexible due diligence requirements, alongside the potential for more favourable capital treatment of private, insurance-backed portfolios, could provide balance sheet relief that would help equity release funders, which may support additional securitisation activity, which has sprung to life (relatively) in recent years. 

    Reading between the lines of Aladhal’s speech, structural change appears almost inevitable.  

    Aladhal was explicit that if later-life lending is to become a true “fourth pillar” of retirement, the market cannot rely entirely on legacy products and funding models. 

    He also said that the regulator wants to see a dismantling of historic negative perceptions and make better consumer outcomes “easier to deliver at scale.”  

    All eyes now turn to the final publication of the market study in Q4 this year, which is expected to show clearly what changes the FCA wishes to make – and therefore, the extent to which the UK will be positioned to provide additional longevity-linked asset capacity to capital markets investors. 

    2026 - June Alternative Credit Alternative Risk Transfer Longevity Risk Volume 2 Issue 7 – July 2026
    Share. Twitter LinkedIn Email

    Related Posts

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026By Greg Winterton

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026By Mark McCord

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026By Greg Winterton

    Editor’s Letter – Volume 2, Issue 7, July 2026

    July 8, 2026By Chris Wells
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.